Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Vicente C, Conchillo A, Garcia-Sanchez MA, Odero MD . The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit Rev Oncol Hematol 2012; 82: 1–17.

    Article  Google Scholar 

  2. Zhang SJ, Ma LY, Huang QH, Li G, Gu BW, Gao XD et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci USA 2008; 105: 2076–2081.

    Article  CAS  Google Scholar 

  3. Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 2011; 43: 1012–1017.

    Article  CAS  Google Scholar 

  4. Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 2011; 43: 929–931.

    Article  CAS  Google Scholar 

  5. Dufour A, Konstandin N, Ksienzyk B, Zellmeier E, Benthaus T, Yaghmaie M et al. High frequency of GATA2 mutations in cytogenetically normal acute myeloid leukemia with biallelic CEBPA mutations identified by exome sequencing. ASH Abstract 2011, 72.

  6. Greif PA, Dufour A, Konstandin NP, Ksienzyk B, Zellmeier E, Tizazu B et al. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood 2012; e-pub ahead of print 30 May 2012.

  7. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.

    CAS  Google Scholar 

  8. Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil GS . Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol Cell Biol 2005; 25: 706–715.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all clinicians for sending samples to our laboratory for diagnostic purposes, and for providing clinical information and follow-up data. In addition, we would like to thank all co-workers at the MLL Munich Leukemia Laboratory for approaching together many aspects in the field of leukemia diagnostics and research. Especially the technical assistance of Madlen Ulke, who performed Sanger Sequencing analyses, is greatly appreciated. In addition, we are grateful for the data management support performed by Tamara Alpermann.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Schnittger.

Ethics declarations

Competing interests

CH, WK, TH and SuS are equity owners of and AF, CE, VG, AK and FD are employed by the MLL Munich Leukemia Laboratory.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fasan, A., Eder, C., Haferlach, C. et al. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia 27, 482–485 (2013). https://doi.org/10.1038/leu.2012.174

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.174

This article is cited by

Search

Quick links